# Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

> **NCT05096338** · — · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer
- Cardiotoxicity
- Drug-Related Side Effects and Adverse Reactions
- Cardiovascular Diseases

## Interventions

- **OTHER:** Social Determinants of Health

## Key facts

- **NCT ID:** NCT05096338
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-27
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- American Heart Association

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096338, "Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05096338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*